Skip to main content

Table 1 Patient characteristics

From: Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study

  CA VATS PVI
Age at procedure – Years (Mean ± SD) 55.5 (8.1) 53.5 (6.7)
BMI (Mean ± SD) 27.8 (4.4) 28.1 (3.8)
LVEF % (Mean ± SD) 64.5 (4.7) 63.5 (7.1)
LA Diameter – mm (Mean ± SD) 42.2 (3.2) 42.3 (5.1)
DC-conversion pre proc. (Mean ± SD) 2.3 (3.0) 1.5 (3.2)
Sex (Male/Female) 8/3 9/1
Hypertension, n (%) 4 (36.4) 3 (30)
Symptoms - EHRA 2, n (%) 5 (45.5) 5 (50)
Symptoms - EHRA 3, n (%) 6 (54.5) 5 (50)
CHADS2 – score 0, n (%) 4 (36.4) 5 (50)
CHADS2 – score 1, n (%) 4 (36.4) 4 (40)
CHADS2 – score 2, n (%) 3 (27.2) 1 (10)
COPD, n (%) 0 0
Diabetes, n (%) 2 (18.2) 0 (0)
AAD - 0 0 1 (10)
AAD - 1 2 (18.2) 1 (10)
AAD - 2 6 (54.5) 3 (30)
AAD – 3 3 (27.3) 3 (30)
AAD - 4 0 0
AAD - 5 0 2 (20)